Optometric physicians often serve as the primary point of detection of geographic atrophy (GA) which is the defining lesion of atrophic AMD. Multimodal imaging is essential to detect, monitor, and quantify GA lesions. This course will explore early high-risk OCT biomarkers that predict or predispose to future GA development as well as OCT and fundus autofluorescence features that predict expansion. Emerging complement inhibitor therapies will be introduced.
Over 1100 attended our event and we received amazing feedback!
Feedback from anonymous survey:
Dr. Majcher is a beacon for the Optometry profession and posterior segment pathology. A delightful lecture!
Excellent information on interpretation of OCT images.
Very good information. I feel more confident knowing when to send out or to hold back and monitor very closely. Thank you!
Good explanation of diagnostic test results .
Excellent, very informative talk explained very simply and clearly.
One of the best Presentations I have seen in years!
Helped me with my OCT fundus exams!
Excellent webinar! Never disappointed in Woo U!
Dr. Marcher was able to simplify the subject and present it in a very understandable way. Great lecture!
The way she presented the lecture was systematic and professional, Really I did understand the topic like never before.
Very good direction on how to proceed. Also gave me ideas how our Electronics records should be organized for AMD. Currently electronic records are totally disorganized for AMD.
Never heard of this speaker before but will look for her again. Very good, compact, informative!
Amazing presentation, a ton of info in a short time, Dr Majcher is extremely knowledgeable in this area.
Great lecture, very informative and I learned a lot about how to better interpret my oct images.
Speaker: Carolyn Majcher, OD
Moderator: Dr. Jennifer Stewart
COPE ID: 88930-TD
Category: Trt/Mngmnt Ocular Disease
This event is COPE approved for 1 hour of CE credit.
Thank you to Zeiss Imaging for exhibiting at this event.